Assay Development
Biomedcode has been and is a partner of choice in European and National Research Networks that aim at the study of disease mechanisms and the discovery of novel therapeutics focusing on topics such as Rheumatoid Arthritis, Inflammation, Cancer, Aging etc.
Our Participation in National and European Networks
BioOnChip
A nationally funded collaborative research project aiming at interrogating the applicability of an innovative 3D microfluidic microculture, i.e. tumor-on-chip, in predicting real-time responses to PD1-blockade in NSCLC patients.
sepia
A nationally funded collaborative research project aiming at the development of an optimized preclinical spondyloarthritis platform with integrated high end imaging technology readouts offering capabilities for the continuous monitoring of disease progression as well as its response to treatment.
DrugArt
A nationally funded collaborative research project aiming at the synthesis of novel small molecules against chronic inflammatory diseases, using lead compounds already validated by the team’s researchers.
BreastCaRANKL
A nationally funded collaborative research project aiming at the development of an innovative human-RANKL dependent breast cancer mouse model towards the development of novel preclinical platforms for the evaluation of human therapeutics targeting cancer.
HUPLA
A nationally funded collaborative research project aiming at the development of humanized platforms that will allow the evaluation of therapeutics targeting autoimmune pathologies
INFRAFRONTIER
A funding scheme supporting the development of a world-class research infrastructure that will provide enduring mouse resources and services towards advancing research into human health and disease.
Be The Cure
An IMI (Innovative Medicines Initiative) funded research project aiming to develop new therapies against rheumatoid arthritis.
aDDRess
An FP7 Marie Curie ITN focusing on the study of chromatin dynamics and the DNA damage response also in pathologies such as intestinal inflammation and cancer.
CodeAge
An FP7 Marie Curie ITN focusing on the role of chronic DNA damage in ageing and age-related pathology including arthritis.
TheRAlead
A National Network of Excellence collaborative project aiming to establish a drug pipeline towards the development of novel therapeutic lead compounds targeting arthritis
TARKINAID
A collaborative research project aiming at targeting Src-family kinases for the treatment of chronic autoimmune and inflammatory disorders including arthritis.
masterswitch project
A large scale integrating project focusing on the study of disease mechanisms with the aim to attack steering effectors of Rheumatoid Syndromes with innovative therapy choices.
infla-Care
A large scale integrating project focusing on the understanding of inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies.
MUGEN
FP6 Network of Excellence aiming towards integrated Functional Genomics in Mutant Mouse Models as Tools to Investigate the Complexity of Human Immunological Disease.
R&D
Animal Model Development
Et harum quidem rerum facilis est et expedita mea voluptas fuga quod mea.
Drug Development
Et harum quidem rerum facilis est et expedita mea voluptas fuga quod mea.
Assay Development
Et harum quidem rerum facilis est et expedita mea voluptas fuga quod mea.
Publications
Et harum quidem rerum facilis est et expedita mea voluptas fuga quod mea.
